Suchergebnisse - (Subject:"lopinavir")

PubPharm (2.063)

1

The interplay of poorly soluble drugs in dissolution from amorphous solid dispersions

enthalten in: International journal of pharmaceutics: X | 2024

von Kokott, M. | Breitkreutz, J. | Wiedey, R.

2

Safety and Pharmacokinetics of Lopinavir/Ritonavir Oral Solution in Preterm and Term Infants Starting Before 3 Months of Age

enthalten in: The Pediatric infectious disease journal | 2024

von Bekker, A. | Yang, J. | Wang, J. | +11

3

Physicochemical interaction of rifampicin and ritonavir-lopinavir solid dispersion : an in-vitro and ex-vivo investigation

enthalten in: Drug development and industrial pharmacy | 2024

von Nair, A. | Vullendula, S. | Yarlagadda, D. | +3

4

Physiologically based Pharmacokinetic Model Validated to Enable Predictions Of Multiple Drugs in a Long-acting Drug-combination Nano-Particles (DcNP) : Confirmation with 3 HIV Drugs, Lopinavir, Ritonavir, and Tenofovir in DcNP Products

enthalten in: Journal of pharmaceutical sciences | 2024

von Perazzolo, S. | Shen, D. | Scott, A. | +1

5

A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von Abdullahi, A. | Diaz, A. | Fopoussi, O. | +5

6

Inhibition of Plasmodium falciparum plasmepsins by drugs targeting HIV-1 protease : A way forward for antimalarial drug discovery

enthalten in: Current research in structural biology | 2024

von Mishra, V. | Deshmukh, A. | Rathore, I. | +6

7

Factors associated with the acceptability of Lopinavir/Ritonavir formulations among children living with HIV/AIDS attending care and treatment clinics in Mbeya and Mwanza, Tanzania

enthalten in: PloS one | 2024

von Jiwa, N. | Ketang'enyi, E. | Nganyanyuka, K. | +12

8

The interplay of poorly soluble drugs in dissolution from amorphous solid dispersions

in: International Journal of Pharmaceutics: X | 2024

von Marcel Kokott | Jörg Breitkreutz | Raphael Wiedey

9

Paediatric abacavir-lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study) : an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trial

enthalten in: The lancet. HIV | 2024

von Bekker, A. | Salvadori, N. | Rabie, H. | +10

ErratumIn: Lancet HIV. 2024 Apr 5;:. - PMID 38588690

10

Prevalence and risk factors of metabolic syndrome in Ethiopia : describing an emerging outbreak in HIV clinics of the sub-Saharan Africa - a cross-sectional study

enthalten in: BMJ open | 2023

von Abdela, A. | Yifter, H. | Reja, A. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[207]